Written by Admin | May 19, 2020
Together, the FDA and Aetion, a healthcare technology company, aim to answer questions about the use of diagnostics and medications in the pandemic, and risk factors for COVID-19-related complications in different patient populations, according to Amy Abernethy, MD, PhD, Principal Deputy Commissioner, FDA.
Read More